Standard course
Community- Dose
- 200 mcg
- How often
- Once daily
- How long
- 10 days
Most cited. Courses repeated every 3–6 months.
Draw 3 units20 mg + 3 mL
PreclinicalShort bioregulator peptide
Cartalax
Ala-Glu-Asp (AED)
- Common dose
- ~200 mcg daily for 10–20 days
- Cycle
- 2-week course, about every 4 months
- Vial sizes
- 20 mg
- Typical draw
- 3 units20 mg with 3 mL, 200 mcg
A synthetic three-amino-acid peptide from the Russian bioregulator family, promoted for cartilage and joint support.
Evidence. Cell and animal studies from the developer’s group. The only human data is a small, unregistered example in a patent.
Status
- Approval
- Not approved as a drug in the US or EU. In Russia it is sold as an oral dietary supplement (capsules), not as a medicine.
- Sport (WADA 2026)
- Likely banned in sportNot named on WADA’s 2026 list, but its S0 rule bans drugs with no current human approval anywhere, at all times.
Sport status follows the WADA Prohibited List in force since January 1, 2026; athletes should confirm with their anti-doping organization. Checked October 5, 2026.
Protocol
Community
About 200 mcg once daily for 10 days is most cited. A few guides use 1–10 mg a day.
- Frequency
- Once daily during a course
- Route
- Subcutaneous injection (community)
- Cycle
- 10–20 day courses, repeated every 3–6 months.
2-week course, about every 4 months, shown over 26 weeks
Common protocols
The ways Cartalax is most often run, each tagged with where it comes from.
Higher-dose guides
Community- Dose
- 1–10 mg
- How often
- Once daily
- How long
- 10 days
A minority of guides go 5–50 times higher; one lists 10 mg a day. No human dose-finding data exist for any dose.
Draw 0.15–1.50 mL20 mg + 3 mL
Taking it
Where it goes
Subcutaneous, rotating daily between the abdomen, thigh and upper arm.
If you miss a dose
No published guidance. Resume the next day and don’t double up.
What to expect
- During the 10-day course
Little or nothing noticeable, per guides.
Community - 2–8 weeks after a course
Guides claim joint comfort starts to improve a few weeks after a course. No controlled human data.
Community - Months 2–3 and beyond
Fuller effects claimed after about 3 months or repeat courses. Based on Russian clinical experience, not trials.
Community
Side effects and what to do
Injection-site redness or swelling
Usually mild; rotate sites. Spreading redness, heat or pus means see a doctor.
No side-effect data from trials
Guides call it well tolerated, but no human safety study exists.
Allergic reaction (possible with any injected peptide)
Stop and get emergency care for hives, facial swelling or trouble breathing.
Stop and get medical help
Stop and get medical help for hives, swelling of the face or throat, trouble breathing, or a hot, spreading or pus-filled injection site.
Tracking and pairing
Human studies
No published human studies of Cartalax turned up in our October 2026 review. The evidence note at the top of this page sums up what is known.
Mixing your vial
| Vial | Water | Common dose | Draw | Strength | Action |
|---|---|---|---|---|---|
| 20 mg | 3 mL | 200 mcg | 3 units (0.03 mL) | 6.667 mg/mL |
Some vendors list the sequence as AEDL instead of AED. Confirm it on the COA.
Dose chart
20 mg vialSyringe units for common doses at different water volumes. Select a cell to open it in the calculator.
| Dose | Water added | ||
|---|---|---|---|
| 1 mL | 2 mL | 3 mL | |
| 200 mcg | |||
| 300 mcg | |||
| 400 mcg | |||
| 600 mcg | |||
| 750 mcg | |||
| 1,500 mcg | |||
| 2,000 mcg | |||
U-100 insulin syringe: 100 units is 1 mL. Draws over 100 units show in mL. Faded values are under 2 units, which is hard to measure. Check that your vial holds the larger volumes.
Datasheet
- Half-life
- No reliable value has been published.
- Type
- Peptide, 3 amino acids
- Molecular weight
- 333.3 g/mol
- Formula
- C12H19N3O8
- Sequence
- AED
- Storage before use
- Freezer (about −20 °C) for long-term storage.
- After mixing or opening
- Fridge (2–8 °C); use within about 4 weeks.
- Molecule: PubChem CID 87815447 (H-Ala-Glu-Asp-OH, synonym Cartalax)
- Storage: Community Common practice for research peptides; no approved label exists.
Cautions
- The only human evidence is a patent narrative.
- Sequence mislabeling (AEDL vs AED) has been reported.
Questions
What is Cartalax?
A synthetic three-amino-acid peptide from the Russian bioregulator family, promoted for cartilage and joint support.
Is Cartalax FDA-approved?
Not approved as a drug in the US or EU. In Russia it is sold as an oral dietary supplement (capsules), not as a medicine.
What is the usual Cartalax dose?
From community reports, not established: About 200 mcg once daily for 10 days is most cited. A few guides use 1–10 mg a day. These are the amounts sources reference, not recommendations.
How much water do I mix Cartalax with?
There’s no single right amount, because the water only sets the strength. With 3 mL of bacteriostatic water in a 20 mg vial, the strength is 6.667 mg/mL, so 200 mcg is 3 units on a U-100 insulin syringe. More water makes small doses easier to measure. The dose chart above shows other volumes.
How should Cartalax be stored?
Before mixing: Freezer (about −20 °C) for long-term storage. After mixing: Fridge (2–8 °C); use within about 4 weeks. This is common practice; no product label covers it.
Is Cartalax banned in sport?
Probably. Not named on WADA’s 2026 list, but its S0 rule bans drugs with no current human approval anywhere, at all times.
Has Cartalax been studied in people?
No published human studies turned up in our October 2026 review. The evidence note at the top of this page sums up what is known.
Sources
No primary source establishes a dose for this compound. The ranges above reflect community reports.
Doses tagged Community come from public dosing guides and user reports, checked against at least two of them. Those sites aren’t named here because many of them sell peptides or earn commissions on them.